Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
Sanofi, GSK ink preclinical pacts in hunt for new antibodies
Sanofi is investing in a U.S. biotech’s autoimmune research, while GSK has tapped Oxford BioTherapeutics to discover new cancer antibodies.
Darren Incorvaia
Dec 10, 2025 11:15am
Formation Bio makes $605M play for Lynk's TYK2 inhibitor
Dec 10, 2025 10:27am
ASH: Novartis details ianalumab's phase 3 rare blood disease win
Dec 9, 2025 7:30am
Boehringer's deal frenzy continues with $570M autoimmune pact
Nov 4, 2025 8:00am
Novartis’ phase 3 wins in Sjögren's see high placebo effect
Oct 29, 2025 12:03pm
Kyverna links CAR-T to autoimmune improvements in small trial
Oct 29, 2025 10:00am
